Invasive Pneumococcal Disease Secondary to Acute Otitis Media in a High-Risk Patient: A Case Report and Review of

Joshua Gregory1, Nathaniel Chohrach1, Deepa Iyengar1

  • 1Family and Community Medicine, The University of Texas, Health Science Center at Houston McGovern Medical School, Houston, USA.

Cureus
|October 3, 2022
PubMed

Insights

This case study highlights how Streptococcus pneumoniae can rapidly progress from acute otitis media to severe invasive pneumococcal disease in unvaccinated individuals with risk factors. Timely antibiotics and vaccination are crucial for preventing severe outcomes.

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Clinical Medicine

Background:

  • Streptococcus pneumoniae commonly causes infections like otitis media, sinusitis, and pneumonia, but can lead to invasive pneumococcal disease (IPD).
  • Pneumococcal vaccination has reduced severe infections, including IPD, meningitis, and pneumonia, particularly in at-risk populations.
  • Risk factors such as obesity, tobacco use, pre-diabetes, and coronary artery disease increase susceptibility to severe pneumococcal infections.

Observation:

  • A unique case of disseminated Streptococcus pneumoniae meningitis and bacteremia originating from acute otitis media (AOM) is presented.
  • The patient, unvaccinated and with multiple comorbidities, experienced rapid progression from AOM to life-threatening invasive pneumococcal infection.
  • Initial presentation with AOM masked the severity of the underlying disseminated infection.

Findings:

  • Prompt antibiotic administration was critical in successfully treating the invasive pneumococcal infection.
  • The patient's comorbidities significantly contributed to the rapid and severe progression of the disease.
  • Lack of pneumococcal vaccination was a key factor in the patient's vulnerability.

Implications:

  • This case underscores the importance of considering invasive pneumococcal disease even with seemingly common initial presentations like AOM in high-risk individuals.
  • Updates to pneumococcal vaccination guidelines for high-risk populations are essential for preventing severe disease.
  • Early recognition and treatment, alongside vaccination strategies, are vital for managing and preventing invasive pneumococcal infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
302
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
369
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
429
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
430